Wednesday, June 10, 2026

pharma Β· Schizophrenia Β· Narcolepsy Type 1

Alkermes Pharma Ireland

Alkermes Pharma Ireland trial registry β€” 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Dublin, USA HQ
27 Employees
EMA registrant Type
Company details
Status
Public
HQ
Dublin, USA
Employees
27
Programs
6
Drugs
3
Patents
25
Intelligence Β· Clinical Trials

Alkermes Pharma Ireland clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to Alkermes Pharma Ireland programs β€” each row shows trial ID, program name, phase, status, and indication.

Alkermes Pharma Ireland trial registry β€” 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Alkermes Pharma Ireland.

  1. ALKS 2680-301 β€” Phase 3

    Clinical update
  2. ALKS 2680-203 β€” Phase 2

    Clinical update
  3. ALKS 2680-202 β€” Phase 2

    Clinical update
  4. ALKS 2680-201 β€” Phase 2

    Clinical update
  5. ALKS 9072, Low Dose β€” Phase 3

    Clinical update
  6. ALKS 9072 β€” Phase 3

    Clinical update

Trial registry

6 studies